News & Insights
Do Better, Dose Better – Berry Goes Beyond Drug Delivery at DDL 2023
Inhalation solutions that deliver a better patient experience, including improved adherence and administration, will be showcased by Berry Global at this year’s DDL Conference. Leveraging the company’s sustainable design expertise and over 50 years of experience in the development of respiratory drug delivery devices, the new inhalation products help deliver a better healthcare experience by improving quality of care while helping to reduce costs and supporting the circular economy.
Berry Global Underlines Its Commitment to South East Asia Region
Berry Global will demonstrate its commitment to delivering innovative, patient-centric packaging, dispensing solutions, and drug delivery devices for India and the South Asia region on the company’s stand at this year’s CPHI India exhibition.
How Digital Cap Technology Can Improve Medicine Adherence
The fast development of vaccines in the face of the Covid-19 pandemic demonstrated the skills and expertise of the pharmaceutical industry. However, the speedy response to this global crisis belies the fact that in many cases, the product development process for a new drug or treatment can be very lengthy and costly, with no guarantee that it will be approved for commercialization.
Berry's PneumoHaler Enables Better Patient Administration and Speed-to-Market
Berry Global Healthcare has launched the PneumoHaler, a new lightweight, breath-actuated, multi-dose inhaler with a dose indicator for the effective management of asthma and chronic obstructive pulmonary disease (COPD). Designed to provide a ready-to-use solution for new inhalation treatments, the PneumoHaler eliminates the need for pharmaceutical companies to develop their own platforms, enabling the delivery of faster-to-market solutions.